Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen and Postprandial Metabolism in Menopause
NCT02383823Withdrawn
- Sponsor
- Regionshospitalet Herning
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial of estradiol in menopause (5 arms), sponsored by Regionshospitalet Herning. Primary endpoint: Postprandial lipidemia at 3 months. Planned start Aug 2019; status: withdrawn.
02
Drugs
estradiol
03
Conditions
menopause
Beyond the preview
Go deeper on NCT02383823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383823.